Key points are not available for this paper at this time.
No takes yet. Share an insight, caveat, or question.
Optimal prothrombin control may be needed for comparable outcomes; leaves open whether this explains divergent anticoagulant trial results.
Elaine Lloyd (1969) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: